Medicine guide

MYLAN-NAPROXEN/ESOMEPRAZOLE MR

As listed in the register: MYLAN-NAPROXEN/ESOMEPRAZOLE MR

375 mg + 20 mg · tablet (immediate- and delayed-release)

  • Prescription only
  • Muscles, joints and bones
Made by
Mylan Pharmaceuticals Ulc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupMuscles, joints and bonesM01AE52

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byMylan Pharmaceuticals Ulc
Active substanceNaproxen + Esomeprazole (Esomeprazole Magnesium Trihydrate)
Used inMuscles, joints and bones
Strength375 mg + 20 mg
Formtablet (immediate- and delayed-release)
ClassificationM01AE52 · Muscles, joints and bones
Routeoral
Dispensing (as stated by the register)PRESCRIPTION
StatusMarketed
MarketedYes, according to the register
DIN02458608
DPD drug code94575

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • tablet (immediate- and delayed-release)2 products

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.